Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Minimally invasive technology enables earlier detection and faster treatment of lung cancer Broward Health Medical Center announced the acquisition of the Ion™ Endoluminal System. This ...

The two-month-old baby girl hospitalized at Rummo following a sudden illness passed away late Wednesday night, and the hospital management expresses its condolences to the grieving ...

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

When monitoring cough, both subjective and objective measures are needed, but use of objective cough counting tools is lacking in clinical practice, according to a scoping review published in Lancet ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a statement issued Friday. The biotechnology company reported revenue of $6.

Sivelestat significantly reduced the incidence of postoperative acute respiratory distress syndrome (ARDS) compared to ...